Cargando…

888. A Predictive Model for Subtherapeutic Vancomycin Troughs in Adults

BACKGROUND: Vancomycin is a first line agent in the treatment of methicillin-resistant Staphylococcus aureus infections. The ability to predict sub-therapeutic troughs would limit potential for development of resistance. The purpose of this study was to develop a predictive model for sub-therapeutic...

Descripción completa

Detalles Bibliográficos
Autores principales:	Crisp, Sarah, Shrestha, Nabin K, Pallotta, Andrea, Wu, Janet, Ahrens, Christine, Cerrato, Pooja
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9753001/ http://dx.doi.org/10.1093/ofid/ofac492.733

Ejemplares similares

Vancomycin levels are frequently subtherapeutic during continuous venovenous hemodialysis (CVVHD)
por: Wilson, F. Perry, et al.
Publicado: (2012)

2332. Higher Pediatric Vancomycin Dosing Trends Toward Improved Therapeutic Troughs
por: Boeglin, August, et al.
Publicado: (2018)

Impact of Vancomycin Serum Trough Concentrations and Vancomycin AUC/MIC on Vancomycin Response, In-Hospital Outcomes and Acute Kidney Injury in Pediatric Staphylococcus aureus Pneumonia
por: McNeil, Jonathon, et al.
Publicado: (2017)

2226. Trough- Versus AUC-Based Vancomycin Monitoring for Treatment of Acute Pulmonary Exacerbations of Adult Cystic Fibrosis Patients
por: Smith, Darrell, et al.
Publicado: (2023)

Vancomycin levels are frequently subtherapeutic in critically ill patients: a prospective observational study
por: Bakke, V., et al.
Publicado: (2017)

Vancomycin trough level and loading dose
por: Tuon, Felipe Francisco, et al.
Publicado: (2018)

1552. Correlation Between Vancomycin Serum Trough Concentrations and Area Under the Curve in Pediatric Patients
por: Weaver, Krista, et al.
Publicado: (2019)

An Ensemble Model for Prediction of Vancomycin Trough Concentrations in Pediatric Patients
por: Huang, Xiaohui, et al.
Publicado: (2021)

1420. Case Report: Ganciclovir Subtherapeutic Dosing in a Pediatric Patient on Extracorporeal Membrane Oxygenation
por: Murphy, Mark, et al.
Publicado: (2018)

Different Vancomycin Immunoassays Contribute to the Variability in Vancomycin Trough Measurements in Neonates
por: Samardzic, Janko, et al.
Publicado: (2016)

The Whole Price of Vancomycin: Toxicities, Troughs, and Time
por: Jeffres, Meghan N.
Publicado: (2017)

2558. Association of Vancomycin-Induced Acute Kidney Injury with Trough Versus AUC Monitoring in Patients Receiving Extended Durations of Therapy
por: Pitcock, C Tyler, et al.
Publicado: (2023)

220. Acute kidney injury incidence comparison of vancomycin trough-based vs AUC/MIC monitoring at a tertiary care hospital
por: Ruiz Gaviria, Rafael E, et al.
Publicado: (2022)

1424. Examining the Relationship Between Vancomycin Area Under the Concentration–Time Curve and Serum Trough Levels in Adults with Presumed or Documented Staphylococcal Infections
por: Clark, Laura, et al.
Publicado: (2018)

Vancomycin for Dialytic Therapy in Critically Ill Patients: Analysis of Its Reduction and the Factors Associated with Subtherapeutic Concentrations
por: de Freitas, Fernanda Moreira, et al.
Publicado: (2020)

Subtherapeutic Doses of Vancomycin Synergize with Bacteriophages for Treatment of Experimental Methicillin-Resistant Staphylococcus aureus Infective Endocarditis
por: Save, Jonathan, et al.
Publicado: (2022)

888. Improving outcomes with revised preoperative universal decolonization protocol
por: Gnass, Silvia I
Publicado: (2020)

Elevated Vancomycin Trough Concentration: Increased Efficacy and/or Toxicity?
por: Elyasi, Sepideh, et al.
Publicado: (2014)

Relationship between vancomycin-induced nephrotoxicity and vancomycin trough concentration in older adults: A retrospective observational study
por: Dai, Ning, et al.
Publicado: (2023)

675 Outcomes of Acute Bacterial Skin and Skin Structure Infections (ABSSSI) by vancomycin dosing regimen and vancomycin trough serum concentrations in the DISCOVER Program
por: Puttagunta, Sailaja, et al.
Publicado: (2014)

1327. Vancomycin Dosing by AUC(24)/MIC in Comparison to Traditional Trough Dosing in Office Infusion Centers (OICs)
por: Luu, Quyen, et al.
Publicado: (2020)

Trough Concentrations of Vancomycin in Patients Undergoing Extracorporeal Membrane Oxygenation
por: Park, So Jin, et al.
Publicado: (2015)

888. Estimation of the Incidence of RSV-attributable Circulatory and Respiratory Hospital Admissions in Adults in Germany between 2015–2019, Overall and for Specific Conditions
por: Beese, Caroline, et al.
Publicado: (2023)

888. In Vitro Forgiveness of INSTI-Containing Regimens at Drug Concentrations Simulating Variable Adherence
por: Acosta, Rima K, et al.
Publicado: (2021)

The effect of body mass index and creatinine clearance on serum trough concentration of vancomycin in adult patients
por: Pan, Yuyan, et al.
Publicado: (2020)

Acute Cardioembolic Stroke in the Setting of Subtherapeutic Anticoagulation
por: Ambatipudi, Ankit, et al.
Publicado: (2023)

Optimization of time to initial vancomycin target trough improves clinical outcomes
por: Cardile, Anthony P, et al.
Publicado: (2015)

775. Comparison of Initial Vancomycin Costs and Target Attainment Between Trough- and 24-Hour Area Under the Concentration–Time Curve (AUC24)-Guided Dosing
por: Laurent, David, et al.
Publicado: (2019)

Case Report: Subtherapeutic Vancomycin and Meropenem Concentrations due to Augmented Renal Clearance in a Patient With Intracranial Infection Caused by Streptococcus intermedius
por: Fransson, Marcus, et al.
Publicado: (2021)

The association of high Vancomycin trough concentration with acute kidney injury during combination therapy of Piperacillin/Tazobactam and Vancomycin
por: Saito, Syuichiro, et al.
Publicado: (2022)

The trough of disillusionment: A critique of the “transition” paradigm
por: Gülöksüz, S.
Publicado: (2021)

888 Performance Characteristics and Associated Outcomes for an Automated Surveillance Tool for Blood Stream Infection
por: Ridgway, Jessica P., et al.
Publicado: (2014)

349. The impact of Vancomycin dosing by area under the curve over minimal inhibitory concentration (AUC/MIC) versus Trough levels on cumulative Vancomycin dosage and incidence of Acute Kidney Injury (AKI) in patients admitted to intensive care units (ICU)
por: Sahu, Aniruddha, et al.
Publicado: (2023)

Prospective Trial of a Novel Nomogram to Achieve Updated Vancomycin Trough Concentrations
por: Wesner, Amber R., et al.
Publicado: (2013)

Vancomycin in ICU Patients with Gram-Positive Infections: Initial Trough Levels and Mortality
por: Alshehri, Nadiyah, et al.
Publicado: (2020)

Effects of continuous venovenous hemofiltration on vancomycin trough concentrations in critically ill children
por: Peng, Lengyue, et al.
Publicado: (2021)

Alternative approaches to therapeutics and subtherapeutics for sustainable poultry production
por: Tabashsum, Zajeba, et al.
Publicado: (2023)

888. Impact of Mandatory Infectious Diseases Consult on All-cause In-patient Mortality and 30-Day Readmission in Patients with Severe Sepsis
por: Hou, Cindy, et al.
Publicado: (2019)

752 Assessment of Aminoglycoside Dosing at a Large Academic Medical Center
por: Ghamrawi, Riane, et al.
Publicado: (2014)

974. Real World Experience of Posaconazole Therapeutic Drug Monitoring in Oncology Patients: Clinical Implications of Hypoalbuminemia as a Predictor of Subtherapeutic Posaconazole Levels
por: Pasikhova, Yanina, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_9govgv8c0k60s719p83j80hhq4